IOVANCE BIOTHERAPEUTICS, INC. Inventory Write-down
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Inventory Write-down of $2.81 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2026-08-06
- IOVANCE BIOTHERAPEUTICS, INC. inventory write-down for the quarter ending 2026-06-30 was $3.31M, a 60.15% decline year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. inventory write-down for the quarter ending 2026-03-31 was -$506.00K.
- IOVANCE BIOTHERAPEUTICS, INC. inventory write-down for the quarter ending 2025-12-31 was $3.70M.
- IOVANCE BIOTHERAPEUTICS, INC. inventory write-down for the quarter ending 2025-09-30 was $1.39M.
- IOVANCE BIOTHERAPEUTICS, INC. inventory write-down for fiscal 2025 was $13.40M.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.81M 10-Q · filed 2026-08-06 | $6.51M derived: sum of 3 quarters · filed 2026-08-06 | $7.90M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$506.00K 10-Q · filed 2026-05-07 | $3.20M derived: sum of 2 quarters · filed 2026-05-07 | $4.59M derived: sum of 3 quarters · filed 2026-05-07 | $12.90M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $3.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $5.09M derived: sum of 2 quarters · filed 2026-02-24 | $13.41M derived: sum of 3 quarters · filed 2026-08-06 | $13.40M 10-K · filed 2026-02-24 |
| 2025-09-30 | $1.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $9.71M derived: sum of 2 quarters · filed 2026-08-06 | $9.70M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $8.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $8.31M 10-Q · filed 2026-08-06 | ||
| 2025-03-31 | -$6.00K 10-Q · filed 2026-05-07 | |||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |